首页> 外文OA文献 >Lifetime cost of ischemic stroke in Germany: Results and national projections from a population-based stroke registry - The Erlangen Stroke Project
【2h】

Lifetime cost of ischemic stroke in Germany: Results and national projections from a population-based stroke registry - The Erlangen Stroke Project

机译:德国缺血性中风的终生成本:基于人群的中风登记册的结果和国家预测-Erlangen中风项目

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background and Purpose-The number of stroke patients and the healthcare costs of strokes are expected to rise. The objective of this study was to determine the direct costs of first ischemic stroke and to estimate the expected increase in costs in Germany. Methods-An incidence-based, bottom-up, direct-cost-of-ischemic-stroke study from the third-party payer's perspective was performed, incorporating 10-year survival data and 5-year resource use data from the Erlangen Stroke Registry. Discounted lifetime year 2004 costs per case were obtained and applied to the expected age and sex evolution of the German resident population in the period 2006 to 2025. Results-The overall cost per first-year survivor of first-ever ischemic stroke was estimated to be 18 517 euros ( EUR). Rehabilitation accounted for 37% of this cost, whereas in subsequent years outpatient care was the major cost driver. Discounted lifetime cost per case was 43 129 EUR overall and was higher in men (45 549 EUR) than in women (41 304 EUR). National projections for the period 2006 to 2025 showed 1.5 million and 1.9 million new cases of ischemic stroke in men and women, respectively, at a present value of 51.5 and 57.1 billion EUR, respectively. Conclusions-The number of stroke patients and the healthcare costs of strokes in Germany will rise continuously until the year 2025. Therefore, stroke prevention and reduction of stroke-related disability should be made priorities in health planning policies
机译:背景和目的-中风患者的数量和中风的医疗保健费用预计会上升。这项研究的目的是确定首次缺血性中风的直接费用,并估算德国预期的费用增加。方法-从第三方付款人的角度进行了基于事件的,自下而上的直接缺血性卒中成本研究,纳入了Erlangen中风注册中心的10年生存数据和5年资源使用数据。获得了每例患者2004年终生折扣价,并将其应用于2006年至2025年德国居民的预期年龄和性别演变。结果-首次缺血性卒中的第一年幸存者的总费用估计为18517欧元(EUR)。康复费用占这项费用的37%,而在随后的几年中,门诊服务是主要的费用驱动因素。每个案例的折现终生费用总计为43129欧元,男性(45 549欧元)高于女性(41 304欧元)。国家对2006年至2025年的预测显示,男女分别有150万和190万新发缺血性卒中,现值分别为51.5和571亿欧元。结论-直到2025年,德国中风患者的数量和中风的医疗保健费用将持续上升。因此,在健康计划政策中应优先考虑中风的预防和减少与中风相关的残疾

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号